Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.

about

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.

Item

http://www.wikidata.org/entity/Q47633560

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@en

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@nl

type

Item

label

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@en

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@nl

prefLabel

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@en

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@nl

P1476

Pharmacogenetics-based populat ...... in Thai HIV-infected patients.

@en

P2093

Anchalee Avihingsanon

http://www.w3.org/2001/XMLSchema#string

Baralee Punyawudho

http://www.w3.org/2001/XMLSchema#string

Chonlaphat Sukasem

http://www.w3.org/2001/XMLSchema#string

David M Burger

http://www.w3.org/2001/XMLSchema#string

Kanokrat Rungtivasuwan

http://www.w3.org/2001/XMLSchema#string

Narukjaporn Thammajaruk

http://www.w3.org/2001/XMLSchema#string

Siwaporn Mitruk

http://www.w3.org/2001/XMLSchema#string

P2860

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers.

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults.

Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.

Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients

Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.

Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers.

P304

1481-1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS-2017-0128

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kiat Ruxrungtham

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29061086

http://www.w3.org/2001/XMLSchema#string

P921

An Téalainn